Kasper, SiegfriedBonelli, AnnalisaCattaneo, AgneseComandini, AlessandroDi Dato, GiorgioHeiman, FrancaPegoraro, ValeriaPalao, DiegoRoca, MiquelVolz, Hans-Peter2024-09-182024-09-182021-11-02Kasper S, Bonelli A, Cattaneo A, Comandini A, Di Dato G, Heiman F, et al. Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany. Int J Psychiat Clin. 2021 Nov 2;25(4):393-402.1365-1501https://hdl.handle.net/20.500.13003/19762https://hdl.handle.net/20.500.12105/23349Objective: To identify sick leave days (SLD) predictors after starting antidepressant (AD) treatment in patients affected by major depressive disorder (MDD), managed by general practitioners, with a focus on different AD therapeutic approaches. Methods: Retrospective study on German IQVIA(R) Disease Analyser database. 19-64 year old MDD patients initiating AD treatment between July-2016 and June-2018 were grouped by therapeutic approach (AD monotherapy versus combination/switch/add-on). Data were analysed descriptively by AD therapeutic approach, while a zero-inflated Poisson (ZIP) multiple regression model was run to evaluate SLD predictors. Results: 8,891 patients met inclusion criteria (monotherapy: 66%; combination/switch/add-on: 34%). All covariates had an influence on SLD after AD treatment initiation. Focussing on variables that physicians may more easily intervene to improve outcomes, it was found that the expected SLD number of combination/switch/add-on patients was 1.6 times that of monotherapy patients, and the expected SLD number of patients diagnosed with MDD before the decision to start AD treatment was 1.2 times that of patients not diagnosed with MDD. Conclusions: A patient tailored approach in the selection of AD treatment at the time of MDD diagnosis may improve functional recovery and help to reduce the socio-economic burden of the disease.enghttp://creativecommons.org/licenses/by/4.0/Major depressive disorderSick leaveAntidepressantsTherapeutic approachReal world evidenceSick LeaveGeneral PracticeDepressive Disorder, MajorYoung AdultAdultGermanyAntidepressive AgentsHumansMiddle AgedRetrospective Studiesresearch articleAttribution 4.0 International34543170254393-40210.1080/13651501.2021.19721201471-1788International Journal of Psychiatry in Clinical Practiceopen accessAntidepresivosTrastorno Depresivo MayorHumanosPersona de Mediana EdadAdulto JovenAusencia por EnfermedadAlemaniaEstudios RetrospectivosAdultoMedicina General2-s2.0-85115205163698226100001L2013743782